All Pharma News
price-trendAsk Us
Genome & Co. posts data from phase 2 microbiome cancer trial

Genome & Co. posts data from phase 2 microbiome cancer trial
FIERCE BIOTECH
24 Jan 2024
Share Share
Positive Results from Interim Analysis of `GEN-001` Plus avelumab PII Trial

Positive Results from Interim Analysis of `GEN-001` Plus avelumab PII Trial
PR NEWSWIRE
19 May 2023
Share Share
CDMO List Labs Partners with Genome & Company

CDMO List Labs Partners with Genome & Company
CONTRACTPHARMA
23 Sep 2021
Share Share
Rome bags $77M to strike gold in the backwaters of the genome

Rome bags $77M to strike gold in the backwaters of the genome
Nick Paul Taylor FIERCEBIOTECH
14 Sep 2021
Share Share
Genome of South Korea purchases CDMO List Labs for $27M

Genome of South Korea purchases CDMO List Labs for $27M
Kevin Dunleavy FIERCEPHARMA
09 Sep 2021
Share Share
Genome & Company signs second clinical trial collaboration and supply agreement

Genome & Company signs second clinical trial collaboration and supply agreement
BIOSPACE
09 Mar 2021
Share Share
Genome & Company and Debiopharm Join Forces To Create New Highly Specific

Genome & Company and Debiopharm Join Forces To Create New Highly Specific
PRNASIA
24 Feb 2021
Share Share
Genome & Company receives FDA IND clearance for GEN-001

Genome & Company receives FDA IND clearance for GEN-001
PR NEWSWIRE
20 Apr 2020
Share Share